Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 15, 2018 FBO #5987
SPECIAL NOTICE

66 -- Intent to Sole Source

Notice Date
4/13/2018
 
Notice Type
Special Notice
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
 
ZIP Code
20857-0001
 
Solicitation Number
FDA-1197647
 
Archive Date
5/5/2018
 
Point of Contact
Christine L. Russman, Phone: 3017967841
 
E-Mail Address
Christine.Russman@fda.hhs.gov
(Christine.Russman@fda.hhs.gov)
 
Small Business Set-Aside
N/A
 
Description
Document Type: Notice of Intent to Sole Source Solicitation Number: FDA - Sole Source - 1197647 Posted Date: 13 April 2018 Response Date: 20 April 2018 NAICS Code: 334516, Analytical Laboratory Instrument Manufacturing, Small Size Standard 1,000 Employees. The Food and Drug Administration intends to make a sole source award for MiSeq2 Whole Genome Sequencer Service Contract. The award will be made to: Illumina, Inc. 5200 Illumina Way San Diego, CA 92122 In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. Purpose: The purpose of this requirement is to obtain a service contract for the MiSeq whole genome sequencer instrument, if the instrument should malfunction. This instrument is used for tracking and characterization of food-borne pathogens. Because of this sensitive technology, annual maintenance and calibration of this instrument in imperative to ensure quality results. Illumina technicians are the only technicians who can service/repair the Illumina Sequencers. This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within five (5) days after the publication of this synopsis which shall be considered by the agency. Responses received after 5 days or without the required information may not be considered. For information concerning this acquisition contact: Christine Russman Contract Specialist E-mail: Christine.Russman@fda.hhs.gov Tel: (301) 796 - 7841 A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-1197647/listing.html)
 
Place of Performance
Address: Food and Drug Administration, 1 Iberville Drive, Dauphin Island, Alabama, 36528, United States
Zip Code: 36528
 
Record
SN04889438-W 20180415/180413230855-67c20f61225726fbbaeca0092a494bbc (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.